Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Current Leases (2016 - 2025)

Historic Current Leases for Sanara MedTech (SMTI) over the last 10 years, with Q3 2025 value amounting to $338990.0.

  • Sanara MedTech's Current Leases fell 2280.4% to $338990.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $338990.0, marking a year-over-year decrease of 2280.4%. This contributed to the annual value of $358687.0 for FY2024, which is 69.16% down from last year.
  • As of Q3 2025, Sanara MedTech's Current Leases stood at $338990.0, which was down 2280.4% from $182935.0 recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Current Leases peaked at $439129.0 during Q3 2024, and registered a low of $126933.0 during Q1 2021.
  • For the 5-year period, Sanara MedTech's Current Leases averaged around $271871.5, with its median value being $273539.0 (2023).
  • Per our database at Business Quant, Sanara MedTech's Current Leases surged by 8198.34% in 2021 and then crashed by 5353.0% in 2025.
  • Over the past 5 years, Sanara MedTech's Current Leases (Quarter) stood at $203292.0 in 2021, then skyrocketed by 54.42% to $313933.0 in 2022, then rose by 15.05% to $361185.0 in 2023, then decreased by 0.69% to $358687.0 in 2024, then decreased by 5.49% to $338990.0 in 2025.
  • Its last three reported values are $338990.0 in Q3 2025, $182935.0 for Q2 2025, and $229710.0 during Q1 2025.